Medtronic takes minority stakes in ICE catheter developers Beluga Medical, CardioACC

Medtronic

Medtronic

MDT

0.00
  • Medtronic made minority equity investments in private intracardiac echocardiography catheter developers Beluga Medical and CardioACC.
  • Deal targets expansion of the Affera mapping and ablation system, with plans to integrate ICE imaging into the Affera platform.
  • Beluga is premarket-stage in California; CardioACC is early commercial-stage in China with NMPA approval for its ICE system in 2025.
  • Both companies will continue to operate independently.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606030655PR_NEWS_USPR_____CG74370) on June 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.